| Literature DB >> 26553143 |
V Spoorenberg1, S E Geerlings2, R B Geskus3, T M de Reijke4, J M Prins5, M E J L Hulscher6.
Abstract
BACKGROUND: Appropriate antibiotic use in patients with complicated urinary tract infections can be measured by a valid set of nine quality indicators (QIs). We evaluated the performance of these QIs in a national setting and investigated which determinants influenced appropriate antibiotic use. For the latter, we distinguished patient, department and hospital characteristics, including organizational interventions aimed at improving the quality of antibiotic use (antibiotic stewardship elements).Entities:
Mesh:
Substances:
Year: 2015 PMID: 26553143 PMCID: PMC4640398 DOI: 10.1186/s12879-015-1257-5
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Set of Quality Indicators [12]
| Quality indicators | |
|---|---|
| 1 | Perform a urine culture |
| 2A | Prescribe empirical therapy in accordance with the national guideline |
| 2B | Prescribe empirical therapy in accordance with the local guideline |
| 3 | Switch from intravenous to oral therapy within 72 h on the basis of the clinical condition* |
| 4 | Tailor antibiotic treatment on the basis of culture results |
| 5 | Use fluoroquinolones selectively (oral therapy, or in case of anaphylaxis to β-lactam antibiotics) |
| 6A | Duration of antibiotic therapy should be at least 10 days (in accordance with the national guideline) |
| 6B | Duration of antibiotic therapy should be according to the local guideline |
| 7A | Treat UTI in men in accordance with the national guideline |
| 7B | Treat UTI in men in accordance with the local guideline |
| 8 | Replace catheter after initiation of antibiotic treatment |
| 9 | Adapt antibiotic dose according to renal function |
*Fulfilling the criteria for a safe early switch: haemodynamic stability, no gastrointestinal problems at 48 h after admission, no Staphylococcus aureus in the blood culture and the availability of an adequate oral antibiotic, based on culture result, or the availability of oral equivalent of the i.v. antibiotic [33]
Patient characteristics. When not all eligible patients were included (due to missing values) the number of included patients is indicated in the upper row of the cell
| Patients | Internal Medicine | Urology | Total |
|---|---|---|---|
| Male sex* | 381 (40) | 753 (77) | 1134 (58) |
| Age in years, median (IQR) | 74 (27) | 58 (28) | 65 (31) |
| Comorbidity |
|
|
|
| Any | 649 (66) | 388 (40) | 1037 (53) |
| Diabetes mellitus | 282 (29) | 99 (10) | 381 (19) |
| Urological comorbidity and/or kidney disease | 275 (28) | 243 (25) | 518 (26) |
| Urinary catheter | 168 (17) | 104 (11) | 272 (14) |
| Glomerular filtration rate, MDRD (mL/min/1.73m2), mean (SD) |
|
|
|
| 61 (42) | 81 (29) | 70 (38) | |
| Allergy to (any) antibiotics | 63 (6) | 66 (7) | 129 (7) |
| Treated at outpatient department | 30 (3) | 620 (63) | 650 (33) |
| Admission at night (7 PM – 7 AM) |
|
|
|
| 213 (34) | 67 (23) | 280 (30) | |
| Antibiotic therapy within past 14 days | 405 (41) | 283 (29) | 688 (35) |
| Febrile UTI |
|
|
|
| 794 (81) | 386 (39) | 1180 (60) | |
| Positive urine culture |
|
|
|
| 637 (65) | 436 (45) | 1073 (55) |
*Numbers are n (%), unless otherwise indicated
Department characteristics
| Departments | Internal Medicine ( | Urology ( | Total ( |
|---|---|---|---|
| Number of beds, mean (SD) | 67 (22) | 18 (9) | 43 (30) |
| % Female physicians, mean (SD) | 33 (13) | 17 (15) | 25 (16) |
| Teaching hospital department* | 17 (89) | 12 (63) | 29 (76) |
| Residents working at the department | 19 (100) | 16 (84) | 35 (92) |
| Microbiological laboratory in the same building as the department | 12 (63) | 8 (42) | 20 (53) |
| Reporting of a positive urine culture by phone (incidentally or structurally) | 0 | 2 (11) | 2 (5) |
| Structurala education on antibiotics for residents | 14 (74) | 4 (21) | 18 (47) |
| Structural education on antibiotics for senior staff members | 4 (21) | 0 | 4 (11) |
| Audit and feedback (incidentallyb or structurally) | |||
| On antibiotic prescriptionsc, at the department level | 2 (11) | 8 (42) | 10 (26) |
| On antibiotic prescriptionsc, at the individual level | 0 | 2 (11) | 2 (5) |
| On antibiotic resistance rates of the hospital | 9 (47) | 12 (63) | 21 (55) |
| Individual advice (of microbiologist/ pharmacist/ infectious diseases (ID) physician), incidentally or structurally, regarding streamlining therapy on the basis of blood or urine culture result | 16 (84) | 16 (84) | 32 (84) |
| Microbiologist and/or ID physician structurally present at ward rounds discussing antibiotic therapy | 6 (32) | 0 | 6 (16) |
| Quality improvement project concerning antibiotic prescribing in past 3 years | 8 (42) | 7 (37) | 15 (40) |
| Changes in antibiotic procedures or policies in past 3 yearsd | 13 (68) | 14 (74) | 27 (71) |
*Numbers are n (%), unless otherwise indicated
aoccurring repeatedly at fixed moments in time.
boccurring repeatedly but not consequently at fixed moments
cfeedback on the number and classes of antibiotics prescribed by the individual professional or in the department in a certain time period (not specifically for complicated UTIs)
de.g. culture results became electronically available (while previously on paper), (new) local hospital guideline for complicated UTIs became available, ID physician joined medical staff (while previously no ID physician)
Hospital characteristics
| Hospitals |
|
|---|---|
| Presence of infectious diseases (ID) physician* | 15 (79) |
| Teaching hospital for microbiologists | 11 (58) |
| Teaching hospital for ID fellows | 4 (21) |
| Structural ID meetings | 13 (68) |
| Specialism of the chairman of the antibiotic committee | |
| ID physician | 3 (16) |
| Clinical pharmacologist | 2 (11) |
| Microbiologist | 13 (68) |
| No antibiotic committee | 1 (5) |
| Local resistance rates used in determining local guideline | 16 (84) |
| Antibiotic prescribing policies | |
| Antibiotic formulary | 17 (89) |
| Restrictive use of certain antibioticsa | 7 (37) |
| Selective reporting of culture result | 11 (58) |
| Automatic stop-order | 1 (5) |
| Accessibility of local antibiotic guidelines | |
| On paper | 2 (11) |
| Digital | 9 (47) |
| Both | 7 (37) |
| None (no local antibiotic guideline) | 1 (5) |
*Numbers are n (%), unless otherwise indicated
aPermission of a microbiologist or ID physician required before using it
Multivariate associationsa between patient (P), department (D) and hospital (H) characteristics and QI performance scores, and explained variance.
| QI | Odds ratio (95 % CI) |
| |
|---|---|---|---|
| 1 | Perform a urine culture | ||
| P | Febrile UTI | 1.98 (1.49-2.63) | <0.001 |
| D | Residents working at department | 3.38 (1.60-7.14) | 0.001 |
| Explained variance (%) | 12.6 | ||
| 2A | Prescribe empirical therapy according to national guideline | ||
| P | Admission at night | 0.61 (0.43-0.86) | 0.007 |
| P | Urinary catheter | 0.15 (0.10-0.22) | <0.001 |
| H | Presence of infectious diseases (ID) physician | 2.52 (1.27-5.01) | 0.008 |
| H | Antibiotic formulary | 2.98 (1.33-6.67) | 0.008 |
| Explained variance (%) | 19.4 | ||
| 2B | Prescribe empirical therapy according to local guideline | ||
| P | Febrile UTI | 1.75 (1.23-2.49) | 0.002 |
| P | Antibiotic therapy within past 14 days | 0.68 (0.52-0.90) | 0.007 |
| P | Urinary catheter | 0.47 (0.31-0.71) | <0.001 |
| D | Structural education on antibiotics for senior staff members | 10.39 (2.83-38.15) | <0.001 |
| Explained variance (%) | 23.7 | ||
| 3 | Switch from iv to oral therapy within 72 hours on the basis of the clinical condition | ||
| P | Older age | 0.85 (0.75-0.95)b | 0.005 |
| D | Feedback on antibiotic prescription at the department level | 0.25 (0.10-0.59) | 0.002 |
| D | Higher proportion female physicians | 0.70 (0.55-0.90)c | 0.005 |
| Explained variance (%) | 26.5 | ||
| 4 | Tailor antibiotic treatment on the basis of culture results | ||
| D | Feedback regarding pathogen-directed therapy on the basis of blood or urine culture result | 0.23 (0.11-0.48) | <0.001 |
| Explained variance (%) | 11.1 | ||
| 6A | Duration of antibiotic therapy should be at least 10 days | ||
| P | Febrile UTI | 2.22 (1.62-3.05) | <0.001 |
| P | Female patient | 0.44 (0.33-0.58) | <0.001 |
| Explained variance (%) | 12.3 | ||
| 6B | Duration of antibiotic therapy should be according to local guideline | ||
| P | Female patient | 0.59 (0.44-0.80) | <0.001 |
| Explained variance (%) | 15.7 | ||
| 7A | Treat UTI in men according to national guideline | ||
| P | Febrile UTI | 2.33 (1.60-3.40) | <0.001 |
| D | Quality improvement project in past 3 years | 0.46 (0.27-0.77) | 0.004 |
| D | Feedback on antibiotic resistance rates of the hospital | 2.07 (1.19-3.61) | 0.01 |
| Explained variance (%) | 17.6 | ||
| 7B | Treat UTI in men according to local guideline | ||
| D | Quality improvement project in past 3 years | 0.29 (0.13-0.65) | 0.003 |
| Explained variance (%) | 17.1 |
aData are presented as Odds Ratios (95 % confidence interval); an Odds Ratio > 1 means a positive association with the QI and an Odds Ratio < 1 means a negative association.
bOR per 10 years increase in age (per 1 year increase in age: OR 0.98; 95 % CI: 0.97-1.00).
cOR per 10 % increase in proportion female physicians (per % increase: OR 0.97; 95 % CI: 0.94-0.99).
Fig. 1Department performance scores on the QIs. Box-percentiles plots show the proportional distribution. Departments are indicated by vertical black lines ( | ). The box contains 90 percent of all departments. The median and the 30th and 70th percentiles are marked with a vertical blue line